Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
Part of paid clinical trials in Portsmouth, Virginia.
- Sponsor
- United States Naval Medical Center, Portsmouth
- Study ID
- NCT06488001
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Postoperative Nausea and Vomiting
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 79 Years
- Healthy Volunteers
- Accepted
Interventions
- pantoprazole — DRUGPantoprazole 40mg given the night before surgery, 2 hours prior to surgery, and the evening after surgery.
- Placebo — DRUGPlacebo given the night before surgery, 2 hours prior to surgery, and the evening after surgery.
Study Details
The goal of this clinical trial is to see if pantoprazole (a proton pump inhibitor used for acid reflux/heart burn) can reduce nausea and vomiting after gynecologic surgery in women between the ages of 18 and 79. Researchers will compare a placebo to the active medication. Participants will be asked to take three pills around their surgery, two taken before and one taken the night after.
Key Dates
- Start date
- Aug 26, 2022
- Status verified
- May 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 132 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Placebo Comparator: PlaceboThis arm receives the placebo drug. This medication is taken the night before, 2 hours before surgery, and the night after surgery.
- Active Comparator: ActiveThis arm receives the pantoprazole 40mg tablet. This medication is taken the night before, 2 hours before surgery, and the night after surgery.
Primary Outcome Measure
Postoperative Nausea and Vomiting [ Time Frame: From enrollment until their postoperative visit at 6 weeks ]
Central Contacts
- Casey Timmerman, DO757-953-7767
- Melissa Infosino, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Naval Medical Center Portsmouth | Portsmouth | Virginia | 23708 | Casey Timmerman, DO (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Portsmouth, VA
By research site
Related Studies
- Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.Recruiting · University of Pennsylvania · Plainsboro, New Jersey